Thermo Fisher Scientific stock: $5 billion buyback expands capital returns
Published on 11/13/2026 at 00:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Investors Should Watch
- The board authorization replaces the previous repurchase program, which had 1 billion dollars remaining.
- Thermo Fisher serves research, diagnostics and biopharma customers through a broad portfolio of laboratory technologies and services.
- The latest stock quote reflects late trading on Lang and Schwarz, while the company event is dated November 5.
Thermo Fisher Scientific Inc. announced on November 5 that its board had authorized a new share-repurchase program. The company said in its investor-relations release that the authorization has no expiration date and replaces its previous program, which had 1 billion dollars remaining.
Capital Returns Gain More Capacity
The decision gives Thermo Fisher additional room to return capital through open-market or negotiated purchases. It does not set a timetable for repurchases, so the authorization itself does not establish the pace or eventual size of actual buybacks.
Thermo Fisher Scientific stock traded at 638.00 euros on Lang and Schwarz at 23:00 CET on Thursday, November 12. The late-session quote provides the latest market reference for investors following the company after the capital-allocation announcement.
Broad Life Sciences Platform
Thermo Fisher Scientific supplies technologies, laboratory products and pharmaceutical services to customers in life sciences research, diagnostics and biopharma. Its brands include Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. The company describes itself as a global leader serving science, with annual revenue of more than 45 billion dollars and operations spanning research support, analytical work, laboratory productivity, diagnostics and therapy development.
Thermo Fisher Scientific profile
- Company: Thermo Fisher Scientific Inc.
- ISIN: US8835561023
- Ticker: TMO
- Home exchange: New York Stock Exchange
- Latest quote: 638.00 euros on Lang and Schwarz, November 12, 2026, 23:00 CET
- Business: Laboratory technologies, diagnostics and pharmaceutical services
Broader market direction remains relevant for large life-sciences companies; follow the S&P 500 market environment.
More news and analyses on Thermo Fisher Scientific stock.
